DIM
LENZ

Delta Investment Management’s LENZ Therapeutics LENZ Stock Holding History

Delta Investment Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,017
Closed -$420K – 308
2025
Q3 		$420K Sell
9,017
-10,857
-55% -$399K 0.08% 168
2025
Q2 		$583K Sell
19,874
-4,127
-17% -$112K 0.11% 120
2025
Q1 		$617K Buy
24,001
+4,760
+25% +$117K 0.12% 100
2024
Q4 		$555K Buy
+19,241
New +$587K 0.11% 119

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Delta Investment Management's LENZ Position: Q4 2025 in Review

Delta Investment Management sold out of LENZ Therapeutics (LENZ) in Q4 2025, closing a stake of 9,017 shares — an estimated $420K sold.

Delta Investment Management first reported a position in LENZ in Q4 2024 and held it in 4 quarters. The position peaked at $617K in Q1 2025. 160 funds tracked by Wall St. Rank hold LENZ as of Q4 2025.

  • Delta Investment Management reported no remaining LENZ Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Delta Investment Management sold 9,017 LENZ Therapeutics shares in Q4 2025, an estimated $420K.
  • Delta Investment Management first reported a position in LENZ Therapeutics in Q4 2024 and held it in 4 quarters.
  • Delta Investment Management's LENZ Therapeutics position peaked at $617K in Q1 2025.
  • 160 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q4 2025.

Based on Delta Investment Management's 13F filing for Q4 2025, filed 30 Jan 2026.